Creative BioMolecules, Inc.
🏢 View company profile →73Patents
0Active
73Granted
37Portfolio score
Filing activity: Feb 24, 1986 → Aug 15, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5091513A | Biosynthetic antibody binding sites | Emerging Cross-Sectional Technologies | 590 | Expired |
| US5258498A | Polypeptide linkers for production of biosynthetic proteins | Emerging Cross-Sectional Technologies | 534 | Expired |
| US5132405A | Biosynthetic antibody binding sites | Emerging Cross-Sectional Technologies | 366 | Expired |
| US5476786A | Biosynthetic antibody binding sites | Chemistry; Metallurgy | 191 | Expired |
| US5482858A | Polypeptide linkers for production of biosynthetic proteins | Emerging Cross-Sectional Technologies | 168 | Expired |
| US4975526A | Bone collagen matrix for zenogenic implants | Emerging Cross-Sectional Technologies | 161 | Expired |
| US5013653A | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage | Chemistry; Metallurgy | 138 | Expired |
| US5108753A | Osteogenic devices | Emerging Cross-Sectional Technologies | 127 | Expired |
| US5877305A | DNA encoding biosynthetic binding protein for cancer marker | Chemistry; Metallurgy | 118 | Expired |
| US5534254A | Biosynthetic binding proteins for immuno-targeting | Chemistry; Metallurgy | 103 | Expired |
| US5011686A | Thrombus specific conjugates | Chemistry; Metallurgy | 76 | Expired |
| US5861156A | Methods of delivering agents to target cells | Chemistry; Metallurgy | 70 | Expired |
| US6093547A | Morphogen cell surface receptor and screening for morphogen analogs | Emerging Cross-Sectional Technologies | 66 | Expired |
| US4743679A | Process for producing human epidermal growth factor and analogs thereof | Emerging Cross-Sectional Technologies | 61 | Expired |
| US5197973A | Synthetic bioadhesive | Human Necessities | 60 | Expired |
| US5525491A | Serine-rich peptide linkers | Chemistry; Metallurgy | 57 | Expired |
| US5149691A | Issue repair and regeneration through the use of platelet derived growth factor (PDGF) in combination with dexamethasone | Human Necessities | 55 | Expired |
| US5906827A | Matrix for the manufacture of autogenous replacement body parts | Human Necessities | 50 | Expired |
| US4888286A | Production of gene and protein analogs through synthetic gene design using double stranded synthetic oligonucleotides | Chemistry; Metallurgy | 49 | Expired |
| US5674844A | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | Physics | 48 | Expired |
| US5376636A | Method for promoting tissue repair and regeneration using PDGF and glucocorticoids | Human Necessities | 46 | Expired |
| US5234908A | Method of treating gastrointestinal ulcers with platelet derived growth factor | Human Necessities | 43 | Expired |
| US5656593A | Morphogen induced periodontal tissue regeneration | Physics | 42 | Expired |
| US5614385A | Methods and compositions for high protein production from recombinant DNA | Chemistry; Metallurgy | 36 | Expired |
| US5084398A | Selective removal of immune complexes | Chemistry; Metallurgy | 36 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.